Technical Analysis with a Quantitative Edge

SIGN UP  |  LOGIN

HOW IT WORKS    TRADE SIGNALS    SCREENER    MY PORTFOLIO    HELP

ACELRX PHARMACEUTICALS INC (ACRX)
Equity - Health Care -

 

As of 2017-12-15

Add to My Portfolio
Close2.05Open1.95
Prev Close1.95Daily Chg+0.10 (+5.13%)
High2.10Volume352,042
Low1.9552-Week High/Low5.50 / 1.75
Dividend Yield0%Curr P/EN/A
Curr Year EPS Est-1.11Fwd P/EN/A
P/BN/AShort Ratio2.51
P/S5.39PEG Ratio0.00
Latest QuantForecast
As Of
Customize QuantForecast   View Commentary & Pattern   Save To My Forecasts     Share

 
 
 

SUPPORT
Lower Boll Band: 1.95
RESISTANCE
9EMA: 2.06 20SMA: 2.13 50SMA: 2.28
COMMENTARY
Strong downtrend across all timeframes . However, Momentum is improving with Slow Stochastics turning higher and Fast Stochastics turning higher and MACD crossing positively. Near-term technicals are oversold with Slow Stochastics near historical low. Intraday buying detected with closing at the highs. Forecast suggests sideways consolidation with negative posture
TECHNICAL PATTERN

TYPEDESCRIPTION (?)CRITERIA (?)
Positive Divergence Price is Moving Lower while Slow Stochastics is crossing Positively Slow Stochastics K Line > Slow Stochastics D Line and 10-Day Chg is Below Zero
Positive Divergence Price is Moving Lower while Fast Stochastics is crossing Positively Fast Stochastics K Line > Slow Stochastics K Line and 10-Day Chg is Below Zero
Buying Pressure Heavy Intra-Day Buying since Open formed wide bullish candle, historically only happened 7.25% of the time Close - Open = 5.13% +- 0.13%
FORECAST STATISTICS
TIMEFRAME 2-DAY 5-DAY 10-DAY 20-DAY
Average -7.45% -9.42% -6.41% +3.79%
Best -1.55% -0.62% +3.07% +14.11%
Worst -22.16% -23.31% -15.83% -7.55%
% Positive 0% 0% 20% 60%
Outlook BEARISH BEARISH BEARISH NEUTRAL
HISTORICAL MATCHES (?)
MATCH DATE 2-DAY 5-DAY 10-DAY 20-DAY
2017-12-15 0% 0% 0% 0%
2016-05-06 -1.55% -0.62% -0.62% +8.05%
2016-03-21 -4.29% -3.07% +3.07% +14.11%
2015-03-18 -1.89% -10.40% -7.33% +9.22%
2014-09-24 -22.16% -23.31% -15.83% -4.89%
2013-03-06 -7.36% -9.72% -11.32% -7.55%
# Matches 5
TRADE SIGNALS ?
POSITIONENTRY DATEENTRY PRICETARGET PRICE (?)STOP PRICE (?)CURRENT PNL %
Premium Members Only

Upgrade Now & Subscribe to Daily Trade Signals

CLOSED TRADES
POSITIONENTRY DATEENTRY PRICEEXIT DATE EXIT PRICEREALIZED PNL %
Long 2017-09-08 3.30 2017-10-05 5.05 +53.03%
Short 2017-07-13 2.15 2017-07-14 2.40 -11.63%
Short 2016-10-07 3.71 2016-10-20 3.20 +13.75%
Short 2016-06-09 3.35 2016-06-29 2.70 +19.40%
Long 2016-01-08 3.44 2016-01-13 2.98 -13.37%
Long 2012-05-15 3.65 2012-05-23 3.45 -5.48%
LATEST BUZZ
@ChartMill
Posted 2017-12-18T04:22:07Z
Measured over the past 5 years, $ACRX shows a very strong growth in Revenue. The Revenue has been growing by 41 ... https://www.chartmill.com/analyze.php?utm_source=stocktwits&utm_medium=FA&utm_content=GROWTH#/ACRX?key=f92f7b73-900a-464a-b192-03502d4323ad
@VolumeBot
Posted 2017-12-17T13:34:59Z
Short volume percent for $ACRX was 32.6% on 12-15-17 http://www.volumebot.com/?s=ACRX
@EstimizeAlerts
Posted 2017-12-17T10:20:19Z
$ACRX estimates distribution - here’s what 5 Estimize analysts are expecting $ACRX to report for Q4 [Reporting 03/01 AMC] http://www.estimize.com/intro/acrx?utm_content=ACRX&utm_medium=distribution&utm_source=stocktwits#chart=scatter-plot
@banana22
Posted 2017-12-16T17:52:10Z
$ACRX That is the definition of a pump-and-dump scam.
@banana22
Posted 2017-12-16T17:51:57Z
$ACRX There needs to be a lawsuit brought against all those who bought this for the PDUFA run-up and sold prior to the October decision.
@ChartMill
Posted 2017-12-16T00:43:07Z
$ACRX: When comparing the growth rate of the last 5 years to the growth rate of the upcoming 2 years, we see th ... https://www.chartmill.com/analyze.php?utm_source=stocktwits&utm_medium=FA&utm_content=GROWTH#/ACRX?key=f92f7b73-900a-464a-b192-03502d4323ad
@jonj711
Posted 2017-12-15T21:01:14Z
$ACRX nice green day!
@raylin
Posted 2017-12-15T20:20:23Z
$ACRX Run baby, you have a big month coming! Plenty of cash, EU partner, two FDA resubmits in the que, EU decision on Dsuvia.
@farid501
Posted 2017-12-15T19:47:53Z
$ACRX Smart if acrx has already started on plan B if A fails from the meeting.Plan B being 50 pat.data @ hi dose as FDA req in the CRL
@raylin
Posted 2017-12-15T16:57:13Z
$ACRX January - FDA mtg on Dsuvia CRL and that info will improve Zalviso resubmit....could be a strong month.
@blabarca
Posted 2017-12-15T15:32:27Z
$ACRX
@EstimizeAlerts
Posted 2017-12-15T15:05:17Z
Here’s what 5 Estimize analysts believe $ACRX will report for Q4 2017 revenue [Reporting 03/01 AMC] http://www.estimize.com/intro/acrx?utm_content=ACRX&utm_medium=revenue_update&utm_source=stocktwits#chart=historical
@shortvolumes
Posted 2017-12-14T23:45:22Z
Short volume ratio for $TRVN on 2017-12-13 is 0.55. http://shortvolumes.com/?t=TRVN $CARA 0.48 $ACRX 0.35 $CYTK 0.42 $FLXN 0.48 via @shortvolumes
@Baidewei2
Posted 2017-12-14T19:23:09Z
$DAVE $ANY $GNC $RRC $AR $M $ACRX $DPW $TEUM
@Newbie72
Posted 2017-12-14T15:33:06Z
$ACRX in a month, over $3
@tdog518
Posted 2017-12-14T15:20:30Z
$ACRX long
@cboneofenglewood
Posted 2017-12-14T14:14:32Z
$PSDV $AEZS $ACRX
@ChartMill
Posted 2017-12-14T02:00:07Z
A Quick Ratio of 4.71 indicates that $ACRX has no problem at all paying its short term obligations. https://www.chartmill.com/analyze.php?utm_source=stocktwits&utm_medium=FA&utm_content=HEALTH#/ACRX?r=fa&key=f92f7b73-900a-464a-b192-03502d4323ad
@raylin
Posted 2017-12-13T22:49:58Z
$ACRX From their Dec 2017 Investor Presentation slide deck, filed with the SEC, legit source.
@raylin
Posted 2017-12-13T22:48:41Z
$ACRX Do your DD before buying into posts about an 'imminent' secondary offering. Many variables could cause it, or make it unnecessary
ACRX LATEST NEWS
Biotech Stocks Facing FDA Decision In December
Posted Wed, 29 Nov 2017 07:09:00 Z
Biotech Stocks Facing FDA Decision In December... >>> Read More
Health Care Sector Update for 10/20/2017: CELG,ACRX,DRRX
Posted Fri, 20 Oct 2017 20:19:33 Z
Top Health Care StocksTop Health Care Stocks JNJ 0 14 JNJ 0 14 PFE 0 31 PFE 0 31 ABT 0 74 ABT 0 74 MRK 0 28 MRK 0 28 AMGN 0 51 AMGN 0 51 Health care stocks climbed a short way past their starting marks today with the NYSE Health Care Index rising almost 0 3 while shares of... >>> Read More
Health Care Sector Update for 10/20/2017: QURE, ACRX, DRRX
Posted Fri, 20 Oct 2017 17:19:38 Z
Top Health Care StocksTop Health Care Stocks JNJ 0 07 JNJ 0 07 PFE 0 34 PFE 0 34 ABT 0 27 ABT 0 27 MRK 0 05 MRK 0 05 AMGN 1 11 AMGN 1 11 Health care stocks were stradding their starting marks today with the NYSE Health Care Index rising over 0 2 while shares of health... >>> Read More
AcelRx's Opioid Painkiller Dsuvia Gets CRL, Shares Plunge
Posted Fri, 13 Oct 2017 17:12:47 Z
AcelRx Pharmaceuticals Inc ACRX plunged nearly 60 after it announced that the FDA has issued a complete response letter CRL to its new drug application NDA for Dsuvia The company is looking to get Dsuvia tablets approved for treating moderate to severe acute pain following a trauma... >>> Read More
INFI Turns Heads, ARDX Marches On, VYGR Cruises Ahead, ACRX Disappoints
Posted Thu, 12 Oct 2017 22:06:00 Z
INFI Turns Heads, ARDX Marches On, VYGR Cruises Ahead, ACRX Disappoints... >>> Read More

WINGCHARTS.COM    HOW IT WORKS    TRADE SIGNALS    SCREENER    MY PORTFOLIO    HELP

 



Follow Us on StockTwits
Partners / Affiliates

Copyright © 2017 WingCapital Co., Ltd. All Rights Reserved.

Disclaimer: Past results are not necessarily indicative of future performance. This website is for educational purposes only. No content published in this website, services and products constitutes a recommendation that any particular investment, security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Practical use of the content, forecasts, charts and services provided in this website are at your own risk and WingCapital Co., Ltd., WingCharts.com, its partners, representatives and employees assume no responsibility or liability for any use of the website. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Trade signals shown are hypothetical and do not represent actual trades. Actual results may differ. Views, forecasts and commentaries expressed in this website are WingCapital Co., Ltd.'s own opinions, and are not guarantees of future performance, and are subject to change over time.

WingCharts.com and WingCapital Co., Ltd. are not registered investment advisor or a broker dealer and do not give individualized market advice. The information on this website is for illustration purposes only and should not be considered as a solicitation of an offer on the purchase or sale of any securities. Trading in the securities markets involves substantial risk and should not be undertaken without due diligence and serious independent study. WingCapital Co., Ltd. recommends consulting a licensed professional broker regarding your personal investments. Without limitation, WingCapital Co., Ltd. shall not be responsible or liable for any loss or damages related to, either directly or indirectly, (1) any decline in market value or loss of any investment; (2) a subscribers inability to use or any delay in accessing the WingCharts.com website or any other source of material provided by WingCharts.com and WingCapital Co., Ltd.; (3) any absence or error of material on WingCharts.com website or presentation; (4) WingCapital Co., Ltd. failure to deliver or delay in delivering any material or (5) any kind of error in transmission of material.

ALL INFORMATION AND MATERIALS ARE PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, WITHOUT LIMITATION ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.